Best in Biotech 4 Apr 2024
Regenerative medicine and tissue engineering: Six companies leading the way
Discover six innovative companies leading the way in the evolving landscape of the tissue engineering and regenerative medicine industry.
Partnerships
- Latest Posts
Best in Biotech 2 Apr 2024
Chicago biotech: Seven players advancing the industry
Chicago is a prominent city for biotech with a blend of established entities and promising startups. Delve into Chicago’s biotech ecosystem.
Best in Biotech 28 Mar 2024
Are these T cell receptor (TCR) therapy companies on your radar?
As biotechs step up in the TCR therapy space, here are seven companies with promising candidates in the clinic.
In Depth 21 Mar 2024
Biotech in France: What’s holding back progress and how to move forward?
Explore the latest insights from France Biotech’s ‘Panorama France HealthTech’ report, uncovering key insights of the French biotech sector.
Best in Biotech 5 Mar 2024
Fourteen biotech companies with market caps exceeding $100 billion
Discover the biotech leaders with a market capitalization exceeding $100 billion, driving innovation and shaping tomorrow’s breakthroughs.
Best in Biotech 20 Feb 2024
Biotechs in the US Capital: seven key players based in Washington DC
Dive into the vibrant biotech scene of Washington D.C. with our article spotlighting the pioneering biotech companies leading the charge.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 8 Feb 2024
Fourteen biotech companies spearheading the antibody drug conjugate industry
The antibody-drug conjugate market has gained significant traction recently. Discover some of the top ADC companies in the industry.
Weekly Roundup 15 Dec 2023
Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered
What’s been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.
Weekly Roundup 8 Dec 2023
Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer
What’s been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.
News and Trends 7 Dec 2023
BIO-Europe 2023: top ten highlights
The biopharma community met at Munich in Germany for BIO-Europe 2023, where attendees from across the world took part in networking events to foster collaboration, last month. With a turnout of nearly 6000 participants and more than 150 exhibitors, the event hosted a number of panel discussions. In collaboration with our parent company, life science […]
News and Trends 1 Dec 2023
Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered
Here is Labiotech’s weekly roundup of the latest biotech news. Stay in the loop by subscribing to our newsletter for direct updates to your inbox. The latest biotech news in fundraising In the news this week, biotech Arvinas raises $350 million PIPE American protein degradation company Arvinas has bagged $350 million in a private placement (PIPE). The […]
Weekly Roundup 24 Nov 2023
Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA
Here is Labiotech’s weekly roundup of the latest biotech news. Whether it is partnerships, clinical trials, or fundraising, we have got you covered. Stay in the loop by subscribing to our newsletter for direct updates to your inbox. Viva Biotech closes $210 million funding round Chinese company Viva Biotech closed a funding round worth $210 […]
ADVERTISEMENT
